Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
Figure 7
Patients reaching target of ≤7% (a) and ≤6.5% (b) at baseline and end of observation time after treatment with testosterone undecanoate injections for up to 6 years.
